ClinicalTrials.gg
Enrolling by invitationNCT06850857Updated Jun 18, 2025

Multi-Institutional IMPACT Validation

An observational study in Facial Injuries, Mandible Fracture and Le Fort, sponsored by University of Tennessee. Enrolling by invitation at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-18.

Primary conditionOrbital FracturesRegistry: Facial InjuriesReclassifiedWhy we changed it
Registry
Facial Injuries — the first condition term the registry derived for this study.
ClinicalTrials.gg
Orbital Fractures
Why
  1. The study's listed conditions name Orbital Fractures, a narrower term within Facial Injuries.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Tennessee · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to validate a novel patient-reported outcome measure (PROM) for patients suffering maxillofacial trauma: The Integrated Modular Patient-Reported Outcome Assessment for Craniomaxillofacial Trauma (IMPACT). The primary question is:

Are the IMPACT modules valid and reliable measures to study quality-of-life (QOL) in patients with maxillofacial trauma?

Patients presenting for routine clinic follow-up for maxillofacial trauma will be invited to complete the IMPACT in addition to the 15 Dimension (15D) QOL survey as a control.

Read the detailed description

Background: Maxillofacial trauma literature is dominated by objective and physician-rated outcomes, leaving a paucity of patient-reported outcome (PRO) research. In fact, no PRO measure (PROM) has ever been validated in this population, posing a tremendous barrier to our understanding of the patient experience. This project will overcome this barrier by validating a novel PROM designed by our research group: The Integrated Modular Patient-Reported Outcome Assessment for Craniomaxillofacial Trauma (IMPACT). The IMPACT is the first PROM designed for maxillofacial trauma, providing novel insight into the patient experience. In its current form, it is a 4-module survey instrument: one general module for all patients (IMPACT-G) and 3 modules specific to fractures of the nasal (IMPACT-N), orbital (IMPACT-O), and/or jaw (IMPACT-J) regions. Each module takes 2-5 minutes to complete for a total of 2-20 minutes, depending on the injury.

Objectives: This study will be a multi-institutional field test to determine the validity and reliability of using the IMPACT for measuring QOL in patients suffering maxillofacial trauma. The hypothesis is that each IMPACT module and subscale will significantly and at least moderately correlate with the 15D, an established general QOL survey instrument.

Methods: Patients with maxillofacial trauma presenting for routine follow-up within one year from their injury will be invited to complete the IMPACT and the 15D survey. Patients who completed an initial survey and return within one month will be invited to complete a second follow-up survey. The scores be tested for validity and reliability using multivariable linear regression, Pearson's r, Cronbach alpha, and test-retest reliability. The sensitivity to change and minimally clinically important difference (MCID) will also be calculated.

Impact: Validation of the first PROM for maxillofacial trauma is anticipated to have a significant and lasting impact in the field of maxillofacial trauma. This will allow researchers and clinicians to better understand the patient experience and make management recommendations accordingly. Integrating the IMPACT into future studies may revolutionize the field by providing novel evidence for controversial topics such as maxillomandibular fixation techniques, surgical approaches, adjunctive therapies, and more.

02

Conditions studied

  • Facial Injuries
  • Mandible Fracture
  • Le Fort
  • Zygomaticomaxillary Complex Fracture
  • Nasal Fracture
  • Orbital Fractures
  • Zygoma Fracture
  • Orbital Floor Fracture
  • Facial Laceration

Browse trials for

Keywords

  • Facial Trauma
  • Maxillofacial Trauma
  • Patient-Reported Outcomes
  • Quality of Life
  • IMPACT
  • Mandible Fracture
  • Midface Fracture
  • Orbital Fracture
  • Nasal Fracture
03

In context

Orbital Fractures Reclassified

29 studies on the registry are indexed under Orbital Fractures; 6 are open to participants now.

Browse Orbital Fractures studies →

Lead sponsor

University of Tennessee is the lead sponsor of 142 studies on the registry; 21 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Compared within Orbital Fractures, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Facial Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be identified from the population of patients presenting to clinics where facial trauma is managed, including otolaryngology, oral and maxillofacial surgery, plastic surgery, and/or ophthalmology clinic(s).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of maxillofacial trauma (fracture of any facial bone[s] and/or soft tissue injury) within 12 months of recruitment date.

Exclusion criteria

Exclusion Criteria:

  1. Patients presenting to clinic for reasons not related to maxillofacial trauma.
  2. Patients with isolated fractures of the cranium or teeth.
  3. Patients who cannot read, write, and/or speak English.
  4. Patients who are unable to provide for themselves (including those who are under 18 years old, incapacitated, intoxicated, or cognitively impaired with a legal guardian)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Nasal Fractures (IMPACT-N)

    This group includes patients with fracture patterns that involve the nasal bones, nasal cavity, and/or sinuses, including: isolated nasal bone fractures, nasoorbitoethmoidal fractures, maxillary sinus fractures, Le Fort I-III fractures, and frontal sinus fractures.

    Other: IMPACT-G Module · Other: IMPACT-N Module · Other: 15D Control Survey

  • Orbital Fractures (IMPACT-O)

    This group includes patients with fracture patterns that involve the orbital walls or rim, including: isolated orbital fractures, zygomaticomaxillary complex fractures, nasoorbitoethmoidal fractures, and Le Fort II-III fractures.

    Other: IMPACT-G Module · Other: IMPACT-O Module · Other: 15D Control Survey

  • Jaw Fractures (IMPACT-J)

    This group includes patients with fracture patterns that involve the upper or lower jaw, including: mandible fractures, dentoalveolar fractures, and Le Fort I-III fractures. Zygomatic arch fractures will also be included given potential impairment of the jaw.

    Other: IMPACT-G Module · Other: IMPACT-J Module · Other: 15D Control Survey

Interventions

  • OtherIMPACT-G Module

    Administration of the general IMPACT survey module.

  • OtherIMPACT-N Module

    Administration of the IMPACT-N survey module.

  • OtherIMPACT-O Module

    Administration of the IMPACT-O survey module.

  • OtherIMPACT-J Module

    Administration of the IMPACT-J survey module.

  • Other15D Control Survey

    Administration of the 15D QOL control survey.

06

What researchers measure

Primary outcomes

  1. Criterion validity: Correlation of IMPACT modules with the 15D QOL control survey

    Criterion validity will primarily be determined by calculating the correlation between each of the IMPACT module total scores and the 15D QOL control survey via Pearson's r, controlling for independent variables that influence survey scores.

    Time frame: When the initial survey is completed (within 12 months of the injury).

Secondary outcomes

  1. Reliability: Covariance of each item in the IMPACT modules and subscales

    The reliability of each module and subscale will be measured via Cronbach alpha's measurement of internal consistency,

    Time frame: When the initial survey is completed (within 12 months of the injury).

  2. Sensitivity to Change: Change in IMPACT scores over the treatment course.

    The sensitivity to change will be evaluated by comparing consecutive IMPACT module and subscale scores for patients who completed the survey two times.

    Time frame: At the completion of the second survey.

  3. Sensitivity to Change: Change in IMPACT scores over the treatment course.

    Follow-up IMPACT scores will be collected 4 weeks from the baseline recruitment and analyzed for improvement from the baseline scores.

    Time frame: Baseline (at recruitement, Day 0) and at 4 weeks.

  4. Minimally Clinically Important Difference (MCID)

    The MCID will be calculated for each IMPACT module and subscale via an anchor-based approach, using a single global question designed to comprehensively assess how the patient feels regarding their facial injury.

    Time frame: When the initial survey is completed (within 12 months of the injury).

Other outcomes

  1. Independent predictors of IMPACT scores

    Independent variables that influence IMPACT scores for each module and subscale will be evaluated, including: demographics (age, sex, race, ethnicity), socioeconomic factors (social-vulnerability index, type of insurance), severity of trauma (Comprehensive facial injury \[CFI\] and Facial Injury Severity Score \[score\]), primary management (observation, closed treatment, and/or maxillomandibular fixation), multisystem trauma, and level of care (discharged from ED, admitted to floor / stepdown, or admitted to ICU).

    Time frame: When the initial survey is completed (within 12 months of the injury).

07

Study locations

3 sites
08

References and documents

Publications

  • Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, Bouter LM, de Vet HCW, Mokkink LB. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018 May;27(5):1159-1170. doi: 10.1007/s11136-018-1829-0. Epub 2018 Mar 17. PubMed 29550964 ↗
  • Ologunde R, McLeod NMH. Use of patient-reported outcome measures in oral and maxillofacial trauma surgery: a review. Br J Oral Maxillofac Surg. 2018 Jun;56(5):371-379. doi: 10.1016/j.bjoms.2018.03.010. Epub 2018 Apr 9. PubMed 29650475 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06850857
Responsible party
Sponsor
First posted
Feb 27, 2025
Start date
Jul 1, 2025 (estimated)
Primary completion
Jun 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jun 18, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion